298 related articles for article (PubMed ID: 25918583)
1. Renal oxidative stress induced by long-term hyperuricemia alters mitochondrial function and maintains systemic hypertension.
Cristóbal-García M; García-Arroyo FE; Tapia E; Osorio H; Arellano-Buendía AS; Madero M; Rodríguez-Iturbe B; Pedraza-Chaverrí J; Correa F; Zazueta C; Johnson RJ; Lozada LG
Oxid Med Cell Longev; 2015; 2015():535686. PubMed ID: 25918583
[TBL] [Abstract][Full Text] [Related]
2. Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia.
Sánchez-Lozada LG; Soto V; Tapia E; Avila-Casado C; Sautin YY; Nakagawa T; Franco M; Rodríguez-Iturbe B; Johnson RJ
Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1134-41. PubMed ID: 18701632
[TBL] [Abstract][Full Text] [Related]
3. Thymoquinone attenuates oxidative stress of kidney mitochondria and exerts nephroprotective effects in oxonic acid-induced hyperuricemia rats.
Dera AA; Rajagopalan P; Alfhili MA; Ahmed I; Chandramoorthy HC
Biofactors; 2020 Mar; 46(2):292-300. PubMed ID: 31758843
[TBL] [Abstract][Full Text] [Related]
4. Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia.
Sánchez-Lozada LG; Tapia E; Soto V; Avila-Casado C; Franco M; Zhao L; Johnson RJ
Nephrol Dial Transplant; 2008 Apr; 23(4):1179-85. PubMed ID: 18048425
[TBL] [Abstract][Full Text] [Related]
5. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats.
Sánchez-Lozada LG; Tapia E; Santamaría J; Avila-Casado C; Soto V; Nepomuceno T; Rodríguez-Iturbe B; Johnson RJ; Herrera-Acosta J
Kidney Int; 2005 Jan; 67(1):237-47. PubMed ID: 15610247
[TBL] [Abstract][Full Text] [Related]
6. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress causes imbalance of renal renin angiotensin system (RAS) components and hypertension in obese Zucker rats.
Luo H; Wang X; Chen C; Wang J; Zou X; Li C; Xu Z; Yang X; Shi W; Zeng C
J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25687731
[TBL] [Abstract][Full Text] [Related]
8. Podocyte Injury and Albuminuria in Experimental Hyperuricemic Model Rats.
Asakawa S; Shibata S; Morimoto C; Shiraishi T; Nakamura T; Tamura Y; Kumagai T; Hosoyamada M; Uchida S
Oxid Med Cell Longev; 2017; 2017():3759153. PubMed ID: 28337250
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulphide and tempol treatments improve the blood pressure and renal excretory responses in spontaneously hypertensive rats.
Ahmad FU; Sattar MA; Rathore HA; Tan YC; Akhtar S; Jin OH; Pei YP; Abdullah NA; Johns EJ
Ren Fail; 2014 May; 36(4):598-605. PubMed ID: 24502512
[TBL] [Abstract][Full Text] [Related]
10. Tempol, a superoxide dismutase-mimetic drug, prevents chronic ischemic renal injury in two-kidney, one-clip hypertensive rats.
Nunes DV; Costa CA; De Bem GF; Cordeiro VS; Santos IB; Carvalho LC; Jordão AK; Cunha AC; Ferreira VF; Moura RS; Resende AC; Ognibene DT
Clin Exp Hypertens; 2018; 40(8):721-729. PubMed ID: 29359965
[TBL] [Abstract][Full Text] [Related]
11. L-arginine or tempol supplementation improves renal and cardiovascular function in rats with reduced renal mass and chronic high salt intake.
Carlström M; Brown RD; Yang T; Hezel M; Larsson E; Scheffer PG; Teerlink T; Lundberg JO; Persson AE
Acta Physiol (Oxf); 2013 Apr; 207(4):732-41. PubMed ID: 23387940
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of uricase blockade plus physiological amounts of fructose-glucose on glomerular hypertension and oxidative stress in rats.
Tapia E; Cristóbal M; García-Arroyo FE; Soto V; Monroy-Sánchez F; Pacheco U; Lanaspa MA; Roncal-Jiménez CA; Cruz-Robles D; Ishimoto T; Madero M; Johnson RJ; Sánchez-Lozada LG
Am J Physiol Renal Physiol; 2013 Mar; 304(6):F727-36. PubMed ID: 23303409
[TBL] [Abstract][Full Text] [Related]
13. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension.
Peixoto EB; Pessoa BS; Biswas SK; Lopes de Faria JB
Am J Nephrol; 2009; 29(4):309-18. PubMed ID: 18849601
[TBL] [Abstract][Full Text] [Related]
15. Impact of elevated uric acid on ventricular remodeling in infarcted rats with experimental hyperuricemia.
Chen CC; Hsu YJ; Lee TM
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1107-17. PubMed ID: 21622823
[TBL] [Abstract][Full Text] [Related]
16. Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system.
Iglarz M; Touyz RM; Viel EC; Amiri F; Schiffrin EL
Am J Hypertens; 2004 Jul; 17(7):597-603. PubMed ID: 15243979
[TBL] [Abstract][Full Text] [Related]
17. Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency.
Eräranta A; Kurra V; Tahvanainen AM; Vehmas TI; Kööbi P; Lakkisto P; Tikkanen I; Niemelä OJ; Mustonen JT; Pörsti IH
J Hypertens; 2008 Aug; 26(8):1661-8. PubMed ID: 18622246
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
[TBL] [Abstract][Full Text] [Related]
19. A role for uric acid in the progression of renal disease.
Kang DH; Nakagawa T; Feng L; Watanabe S; Han L; Mazzali M; Truong L; Harris R; Johnson RJ
J Am Soc Nephrol; 2002 Dec; 13(12):2888-97. PubMed ID: 12444207
[TBL] [Abstract][Full Text] [Related]
20. Tempol blunts afferent arteriolar remodeling in chronic nitric oxide-deficient hypertension without normalizing blood pressure.
Marañon RO; Juncos LA; Joo Turoni C; Karbiner S; Romero D; Peral de Bruno M
Clin Exp Hypertens; 2014; 36(3):132-9. PubMed ID: 23786429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
